Correlation Between Early Dynamics in Circulating Tumour DNA and Outcome From FOLFIRI Treatment in Metastatic Colorectal Cancer

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-47708-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Change in Circulating Tumor DNA After Hepatic Resection for Metastatic Colorectal Cancer

HPB
HepatologyGastroenterology
2018English

Circulating Tumor DNA Detectable in Early- And Late-Stage Colorectal Cancer Patients

Bioscience Reports
BiochemistryCell BiologyMolecular BiologyBiophysics
2018English

FOLFIRI Plus Panitumumab in the Treatment of Wild-Type KRAS and Wild-Type NRAS Metastatic Colorectal Cancer

World Journal of Surgical Oncology
SurgeryOncology
2018English

Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer

JCO Precision Oncology
Cancer ResearchOncology
2019English

Angiogenesis Genotyping and Clinical Outcome During Regorafenib Treatment in Metastatic Colorectal Cancer Patients

Scientific Reports
Multidisciplinary
2016English

Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer

Scientific Reports
Multidisciplinary
2019English

Circulating VEGF and eNOS Variations as Predictors of Outcome in Metastatic Colorectal Cancer Patients Receiving Bevacizumab

Scientific Reports
Multidisciplinary
2017English

Relationship Between Tumour Response and Tumour-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials

Clinical Colorectal Cancer
OncologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy